Connecting people, advancing clinical value
Connecting people, advancing clinical value
The March 2025 MFDS IND approvals provide a valuable snapshot of investigational new drug activity in South Korea. A total of 47 IND approvals were issued during the month; 33 approvals (about 70 %) were for overseas‑sponsored projects and 14…
March 2025 MFDS IND Approvals show that ten investigational medical devices received clearance from South Korea’s Ministry of Food and Drug Safety. Under MFDS regulations and the Digital Medical Products Act, which took effect in January 2025, devices that require…